Alle Studien
RekrutierungPHASE3INTERVENTIONELL

A Study of Sepiapterin in Participants With Phenylketonuria (PKU)

This study is investigating a new medicine called sepiapterin for children who have Phenylketonuria, or PKU. PKU is a rare condition where the body can't properly break down a substance called phenylalanine, which can build up and affect the brain. The main goal of this research is to see if giving sepiapterin to children with PKU from an early age can help keep their brain and thinking skills working well as they grow up. The study will look at how effective the medicine is over a longer period. It's a 'Phase 3' study, which means it's one of the final steps before a medicine might be considered for wider use.

Auf einen Blick

Status
Rekrutierung
Phase
PHASE3
Sponsor
PTC Therapeutics
Einschreibeziel
56
Starten
04 Mar 2024
Geschätzte Fertigstellung
28 Feb 2031

Worum geht es in dieser Studie?

This research is looking into a new medicine called sepiapterin for children living with Phenylketonuria, often called PKU. PKU is a condition that affects how the body processes certain foods. If not treated, a substance called phenylalanine can build up in the body and could affect brain development and learning abilities over time. Current treatments usually involve a special diet and sometimes other medicines.

The main aim of this study is to find out if giving sepiapterin to children with PKU when they are very young can help protect their brain development and thinking skills in the long run. Researchers want to see if it can help them maintain their learning and problem-solving abilities as they get older. This is important because finding effective ways to support children with PKU is a key focus for doctors and scientists.

The study has two main parts. The first part will test how well each child responds to sepiapterin. The second part will involve taking the medicine for a longer period to see its ongoing effects. This is a crucial step in understanding if sepiapterin could be a helpful new treatment option for children with PKU.

Wichtige Erkenntnisse

  • Tests a new medicine (sepiapterin) for PKU in children.
  • Aims to protect brain development when started early.
  • Participants continue their special PKU diet.
  • Involves regular clinic visits and health assessments.
  • It's a long-term study to look at ongoing effects.

Wer könnte berechtigt sein?

To join this study, children need to have a confirmed diagnosis of PKU. For toddlers and young children aged between 2 and a half years and 9 years, their thinking and learning skills (measured by an IQ test) should be within a certain range.

There are also some requirements for blood tests: participants must have certain levels of phenylalanine in their blood before joining, both high enough to confirm PKU, but also showing they can get it below a certain level with their current management. For very young babies (under one month), a high phenylalanine level found during newborn screening is important.

Some things might prevent someone from joining. This includes having allergies to similar medicines, having other serious medical or mental health conditions that aren't well controlled, or if they've recently taken certain other study medicines or treatments for PKU.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Does your child have a confirmed diagnosis of PKU?
  2. Is your child currently less than 10 years old?
  3. If your child is between 2 and a half and 9 years old, have they had a recent IQ score of 80 or higher?
  4. Has your child's phenylalanine level been both high (showing PKU) and sometimes lower (showing good diet management) recently?
  5. Has your child avoided other similar PKU medicines or research drugs recently?
  6. Are there any serious ongoing medical conditions not well-controlled?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If a child takes part in this study, they will have check-ups and tests at the study clinic. The study is split into two parts. In the first part, doctors will check how your child responds to the study medicine, sepiapterin. This involves taking the medicine and having blood tests to see how their phenylalanine levels change. The second part involves taking the study medicine for a longer period.

Throughout the study, children will continue their prescribed special diet for PKU. There will be regular visits to the clinic for medical examinations, blood tests, and assessments of their brain functions and development. The total duration of participation will depend on the specific part of the study and the child's age, and will be explained fully by the study team. Girls and women who could become pregnant will need to use effective birth control during the study and for 90 days after their last dose of medicine.

Potenzielle Risiken und Vorteile

Taking part in this study may offer potential benefits, such as access to a new medicine (sepiapterin) that could help manage PKU and support brain development. However, there are also potential risks, including possible side effects from the medication. The study team will explain all known side effects and monitor participants closely for any new issues. You have the right to withdraw your child from the study at any time, for any reason, without it affecting their regular medical care.

Standorte (14)

  • Indiana University School of Medicine
    Verifizierte Postleitzahl
    Indianapolis, Vereinigte Staaten· Rekrutierung
  • Perth Children's Hospital
    Verifizierte Postleitzahl
    Nedlands, Australia· Rekrutierung
  • Women and Children Hospital
    Verifizierte Postleitzahl
    North Adelaide, Australia· Rekrutierung
  • The Royal Children's Hospital
    Verifizierte Postleitzahl
    Parkville, Australien· Rekrutierung
  • Children's Health Queensland -Queenslan Children Hospital
    Verifizierte Postleitzahl
    Süd-Brisbane, Australien· Rekrutierung
  • Centre Hospitalier Universitaire (CHU) de Lille - Hôpital Jeanne de Flandre
    Verifizierte Postleitzahl
    Lille, Frankreich· Rekrutierung
  • Assistance Publique - Hôpitaux de Paris (AP-HP) - Hôpital Necker-Enfants Malades
    Verifizierte Postleitzahl
    Paris, Frankreich· Rekrutierung
  • Centre Hospitalier Régional Universitaire (CHRU) de Tours - Hôpital Clocheville
    Verifizierte Postleitzahl
    Tours, Frankreich· Rekrutierung
  • Children's Health Ireland (CHI)
    Verifizierte Postleitzahl
    Dublin, Ireland· Rekrutierung
  • Pomorski Uniwersytet Medyczny w Szczecinie
    Verifizierte Postleitzahl
    Szczecin, Poland· Rekrutierung
  • Instytut Matki i Dziecka
    Verifizierte Postleitzahl
    Warschau, Polen· Rekrutierung
  • Karolinska Universitetssjukhuset - Astrid Lindgrens Barnsjukhus
    Verifizierte Postleitzahl
    Stockholm, Schweden· Rekrutierung

Häufige Fragen

What is PKU?

Phenylketonuria (PKU) is a rare genetic condition where the body can't properly process a substance called phenylalanine, which can build up and affect the brain.

What is sepiapterin?

Sepiapterin is the name of the new medicine being tested in this study for treating PKU.

How long will the study last for my child?

The study has two parts, and the length of time your child participates will be discussed in detail by the study team, varying by age and response.

Will my child still need their special PKU diet?

Yes, all children in the study will continue to follow their prescribed special diet for PKU.

What if we change our minds about participating?

You can withdraw your child from the study at any time, for any reason, without it affecting their normal medical care.

Wie Sie mehr erfahren können

Patient Advocacy

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "A Study of Sepiapterin in Participants With Phenylketonuria … wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.